This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Public Health, Other  • Bacterial Infections  • Tuberculosis/ Other Mycobacterium  • Law and Medicine  • Alert me on articles by topic

Mike Mitka

JAMA. 2007;298:618.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The House has approved a measure that would provide a $50 million boost in funding for the prevention, control, and treatment of tuberculosis (TB), notably strains of TB that are resistant to multiple drugs.

The allocation would go to the Child Survival and Health Programs Fund, a provision in Department of State, Foreign Operations and Related Programs Appropriations Act, 2008 (HR 2764 [http://thomas.loc.gov]), passed by the House on June 21.

The House approved a measure that provides $50 million to enhance prevention, control, and treatment of drug-resistant tuberculosis. (Photo credit: Kari Lounatmaa, PhD/www.sciencesource.com)

With the additional money, the Agency for International Development could provide much needed resources around the world to strengthen basic TB control, improve laboratory capacity to detect drug resistance, and scale up capacity to treat drug-resistant strains, said Rep Donald M. Payne (D, NJ), chairman of the House Foreign Affairs Subcommittee . . . [Full Text of this Article]